Ulisse Biomed S.p.A. (BIT:UBM)
Italy
· Delayed Price · Currency is EUR 0.7600
+0.0100 (1.33%)
Apr 28, 2025, 11:42 AM CET
Ulisse Biomed Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 1.5 | 2.79 | 3.79 | 4.99 | 0.04 | Upgrade
|
| Cash & Short-Term Investments | 1.5 | 2.79 | 3.79 | 4.99 | 0.04 | Upgrade
|
| Cash Growth | -46.05% | -26.51% | -23.97% | 11498.55% | -94.46% | Upgrade
|
| Accounts Receivable | 0.32 | 0.53 | 0.13 | 0.23 | 0.37 | Upgrade
|
| Other Receivables | 1.6 | 1.78 | 0.91 | 0.93 | 0.4 | Upgrade
|
| Receivables | 1.92 | 2.31 | 1.04 | 1.16 | 0.77 | Upgrade
|
| Inventory | 1.8 | 1.99 | 0.13 | 0.09 | 0.07 | Upgrade
|
| Total Current Assets | 5.22 | 7.08 | 4.96 | 6.24 | 0.89 | Upgrade
|
| Property, Plant & Equipment | 2.19 | 2.38 | 0.11 | 0.07 | 0.11 | Upgrade
|
| Goodwill | 18.59 | 20.92 | - | - | - | Upgrade
|
| Other Intangible Assets | 0.86 | 1.11 | 0.9 | 0.91 | 0.86 | Upgrade
|
| Long-Term Deferred Charges | 0.28 | 0.4 | 0.59 | 0.79 | - | Upgrade
|
| Other Long-Term Assets | 0.12 | 0.16 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 27.26 | 32.05 | 6.57 | 8.02 | 1.87 | Upgrade
|
| Accounts Payable | 1.44 | 1.95 | 0.19 | 0.25 | 0.24 | Upgrade
|
| Accrued Expenses | 1.34 | 0.16 | 0.06 | 0.02 | 0 | Upgrade
|
| Short-Term Debt | - | 0.08 | 0.01 | 0 | 0 | Upgrade
|
| Current Income Taxes Payable | 0.02 | 0.26 | 0 | 0.02 | 0.03 | Upgrade
|
| Current Unearned Revenue | - | - | 0.1 | - | - | Upgrade
|
| Other Current Liabilities | 0.28 | 0.55 | 0.06 | 0.07 | 0.03 | Upgrade
|
| Total Current Liabilities | 3.07 | 3.01 | 0.41 | 0.37 | 0.3 | Upgrade
|
| Long-Term Debt | 0.33 | 0.41 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | 1.04 | 0.2 | 0.4 | - | Upgrade
|
| Other Long-Term Liabilities | 0.18 | 0.23 | 0.02 | 0 | 0.01 | Upgrade
|
| Total Liabilities | 3.59 | 4.7 | 0.63 | 0.77 | 0.31 | Upgrade
|
| Common Stock | 0.24 | 0.22 | 0.08 | 0.08 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 39.52 | 37.28 | 11.22 | 11.22 | 4.95 | Upgrade
|
| Retained Earnings | -16.76 | -10.82 | -6.02 | -4.71 | -4.11 | Upgrade
|
| Comprehensive Income & Other | 0.66 | 0.67 | 0.67 | 0.67 | 0.67 | Upgrade
|
| Shareholders' Equity | 23.67 | 27.35 | 5.95 | 7.25 | 1.56 | Upgrade
|
| Total Liabilities & Equity | 27.26 | 32.05 | 6.57 | 8.02 | 1.87 | Upgrade
|
| Total Debt | 0.33 | 0.5 | 0.01 | 0 | 0 | Upgrade
|
| Net Cash (Debt) | 1.17 | 2.29 | 3.79 | 4.99 | 0.04 | Upgrade
|
| Net Cash Growth | -48.92% | -39.49% | -24.07% | 11611.25% | -94.50% | Upgrade
|
| Net Cash Per Share | - | 0.11 | 0.47 | 0.62 | - | Upgrade
|
| Filing Date Shares Outstanding | - | 21.57 | 8.06 | 8.06 | - | Upgrade
|
| Total Common Shares Outstanding | - | 21.57 | 8.06 | 8.06 | - | Upgrade
|
| Working Capital | 2.14 | 4.07 | 4.55 | 5.87 | 0.59 | Upgrade
|
| Book Value Per Share | - | 1.27 | 0.74 | 0.90 | - | Upgrade
|
| Tangible Book Value | 4.22 | 5.32 | 5.05 | 6.34 | 0.7 | Upgrade
|
| Tangible Book Value Per Share | - | 0.25 | 0.63 | 0.79 | - | Upgrade
|
| Machinery | - | - | 0.29 | 0.21 | - | Upgrade
|
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.